Notes
Summary of product characteristics. Waiting times for re-administration with neuromuscular blocking agents after reversal with sugammadex. Available from URL: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000885/WC500052310.pdf (accessed March 2011).
References
Staals LM, Snoeck MM, Driessen JJ, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010; 104: 31-9.
de Boer HD, Driessen JJ, van Egmond J, Booij LH. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. Can J Anesth 2008; 55: 124-5.
Cammu G, de Kam PJ, De Graeve K, et al. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study. Br J Anaesth 2010; 105: 487-92.
Kopman AF. Managing neuromuscular block: where are the guidelines? Anesth Analg 2010; 111: 9-10.
Acknowledgments
The authors sincerely thank Professor Aaron F. Kopman, Weill Cornell Medical College, for his helpful assistance with manuscript revision and Dr. Lucas Mengibar Fuentes, vascular surgeon, for his collaboration in patient care.
Conflicts of interest
Gloria Veiga-Ruiz, Nuria Dominguez-Serrano, and Joaquin Fabregat-López have received speakers’ fees from MSD. No external funding and no competing interest declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fabregat-López, J., Veiga-Ruiz, G., Dominguez-Serrano, N. et al. Re-establishment of neuromuscular block by rocuronium after sugammadex administration. Can J Anesth/J Can Anesth 58, 658–659 (2011). https://doi.org/10.1007/s12630-011-9499-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12630-011-9499-1